Neurotherapeutics

4.6(top 5%)

impact factor

1.8K(top 10%)

papers

72.8K(top 5%)

citations

121(top 5%)

h-index

4.7(top 5%)

impact factor

2.1K

all documents

79.3K

doc citations

190(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Diffusion Tensor Imaging of the Brain	Neurotherapeutics	2007	2,186
2	The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review	Neurotherapeutics	2012	1,600
3	Microglial Activation and Chronic Neurodegeneration	Neurotherapeutics	2010	747
4	Inflammation and Stroke: An Overview	Neurotherapeutics	2016	631
5	Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury	Neurotherapeutics	2010	564
6	Role of Microglia in Neurotrauma	Neurotherapeutics	2010	541
7	Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis	Neurotherapeutics	2008	512
8	Glioma Subclassifications and Their Clinical Significance	Neurotherapeutics	2017	471
9	Cannabidiol as a Potential Treatment for Anxiety Disorders	Neurotherapeutics	2015	453
10	Molecular targets for antiepileptic drug development	Neurotherapeutics	2007	427
11	Molecular Targets of Cannabidiol in Neurological Disorders	Neurotherapeutics	2015	413
12	Astrocytes in Alzheimer's Disease	Neurotherapeutics	2010	377
13	Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses	Neurotherapeutics	2018	363
14	Anxiety, Depression, and the Microbiome: A Role for Gut Peptides	Neurotherapeutics	2018	358
15	Targeting Astrocyte Signaling for Chronic Pain	Neurotherapeutics	2010	348
16	Functions of Astrocytes and their Potential As Therapeutic Targets	Neurotherapeutics	2010	329
17	Microglial Activation in Stroke: Therapeutic Targets	Neurotherapeutics	2010	328
18	Antioxidant Therapies for Traumatic Brain Injury	Neurotherapeutics	2010	318
19	Medical Comorbidities in Autism: Challenges to Diagnosis and Treatment	Neurotherapeutics	2010	306
20	Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy	Neurotherapeutics	2011	304
21	Ketone Bodies as a Therapeutic for Alzheimer's Disease	Neurotherapeutics	2008	296
22	Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management	Neurotherapeutics	2016	296
23	Gut Microbiota and the Neuroendocrine System	Neurotherapeutics	2018	295
24	Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials	Neurotherapeutics	2017	294
25	Reactive Astrocytes As Therapeutic Targets for CNS Disorders	Neurotherapeutics	2010	291
26	Classification of Sleep Disorders	Neurotherapeutics	2012	288
27	Responsive Cortical Stimulation for the Treatment of Epilepsy	Neurotherapeutics	2008	282
28	The Endocannabinoid System and its Modulation by Phytocannabinoids	Neurotherapeutics	2015	281
29	Magnetic resonance imaging of myelin	Neurotherapeutics	2007	269
30	Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside	Neurotherapeutics	2009	267
31	Iron in chronic brain disorders: Imaging and neurotherapeutic implications	Neurotherapeutics	2007	266
32	Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice	Neurotherapeutics	2011	260
33	Mechanisms and Targets of Deep Brain Stimulation in Movement Disorders	Neurotherapeutics	2008	258
34	Reaction Time Variability in ADHD: A Review	Neurotherapeutics	2012	255
35	Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options	Neurotherapeutics	2013	255
36	PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's Disease	Neurotherapeutics	2008	254
37	A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) Mice	Neurotherapeutics	2012	248
38	Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan	Neurotherapeutics	2018	248
39	Clinical Trials in Traumatic Brain Injury: Past Experience and Current Developments	Neurotherapeutics	2010	247
40	TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets	Neurotherapeutics	2015	246
41	Cell Death Mechanisms and Modulation in Traumatic Brain Injury	Neurotherapeutics	2010	236
42	Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis	Neurotherapeutics	2015	236
43	Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments	Neurotherapeutics	2009	231
44	Closed-loop Neurostimulation: The Clinical Experience	Neurotherapeutics	2014	227
45	5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease	Neurotherapeutics	2008	226
46	Clinical Utility of EEG in Attention-Deficit/Hyperactivity Disorder: A Research Update	Neurotherapeutics	2012	222
47	Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and Humans	Neurotherapeutics	2016	219
48	Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging	Neurotherapeutics	2007	209
49	Cannabinoids and Epilepsy	Neurotherapeutics	2015	207
50	Convection-Enhanced Delivery	Neurotherapeutics	2017	204

Scientometrics

Overviews

Citing Bodies

Neurotherapeutics

Top Articles